HomeSBHMY • OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
Nakaraang pagsara
$9.65
Sakop ng araw
$9.55 - $9.55
Sakop ng taon
$6.69 - $9.65
Market cap
68.96B HKD
Average na Volume
42.00
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 7.94B | 11.14% |
Gastos sa pagpapatakbo | 4.78B | 10.58% |
Net na kita | 1.51B | 139.69% |
Net profit margin | 19.01 | 115.78% |
Kita sa bawat share | — | — |
EBITDA | 1.98B | 8.88% |
Aktuwal na % ng binabayarang buwis | 16.99% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 13.18B | -15.93% |
Kabuuang asset | 66.70B | 1.62% |
Kabuuang sagutin | 24.58B | -15.76% |
Kabuuang equity | 42.12B | — |
Natitirang share | 18.21B | — |
Presyo para makapag-book | 5.36 | — |
Return on assets | 6.50% | — |
Return on capital | 8.37% | — |
Cash Flow
Net change in cash
(CNY) | Hun 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | 1.51B | 139.69% |
Cash mula sa mga operasyon | 1.54B | 15.25% |
Cash mula sa pag-invest | -1.02B | 49.91% |
Cash mula sa financing | -2.05B | -1.42% |
Net change in cash | -1.52B | 43.37% |
Malayang cash flow | 1.09B | 36.59% |
Tungkol
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.
Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.
Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products. Wikipedia
CEO
Itinatag
2000
Website
Mga Empleyado
24,437